Merck & Co., Inc. (MRK) Q1 2026 Earnings Call Transcript
Merck & Co., Inc. reported its first-quarter 2026 earnings on April 30, 2026, revealing financial results that surpassed analyst expectations. The company achieved revenue growth year-over-year and delivered an earnings per share that beat consensus estimates. Executives discussed performance drivers and strategic priorities during the earnings call with investors and analysts.
- ▪Merck & Co., Inc. reported a Q1 2026 EPS of -$1.28, which beat estimates by $0.19.
- ▪The company recorded Q1 2026 revenue of $16.29 billion, representing a 4.87% increase year-over-year.
- ▪Revenue exceeded expectations by $439.67 million.
- ▪Peter Dannenbaum, Robert Davis, Caroline Litchfield, and Dean Li participated in the earnings call.
- ▪Analysts from firms including Cantor Fitzgerald, BofA Securities, UBS, Goldman Sachs, and JPMorgan Chase asked questions during the call.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4896723-merck-and-co-inc-mrk-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.